220 related articles for article (PubMed ID: 10818025)
21. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
Nightingale JA; Rogers DF; Barnes PJ
Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
[TBL] [Abstract][Full Text] [Related]
23. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
Kelsen SG; Church NL; Gillman SA; Lanier BQ; Emmett AH; Rickard KA; Anderson WH
J Asthma; 1999 Dec; 36(8):703-15. PubMed ID: 10609625
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
[TBL] [Abstract][Full Text] [Related]
25. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
[TBL] [Abstract][Full Text] [Related]
26. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
27. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
[TBL] [Abstract][Full Text] [Related]
28. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
[TBL] [Abstract][Full Text] [Related]
29. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.
Greening AP; Ind PW; Northfield M; Shaw G
Lancet; 1994 Jul; 344(8917):219-24. PubMed ID: 7913155
[TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
31. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
[TBL] [Abstract][Full Text] [Related]
32. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
[TBL] [Abstract][Full Text] [Related]
33. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC; Lindemann L; Braun R; Steinkamp G
Swiss Med Wkly; 2004 Jan; 134(3-4):50-8. PubMed ID: 14745658
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol in paediatric asthma.
Byrnes C; Shrewsbury S; Barnes PJ; Bush A
Thorax; 2000 Sep; 55(9):780-4. PubMed ID: 10950898
[TBL] [Abstract][Full Text] [Related]
35. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group.
Verberne AA; Frost C; Roorda RJ; van der Laag H; Kerrebijn KF
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):688-95. PubMed ID: 9309980
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.
Davies B; Brooks G; Devoy M
Respir Med; 1998 Feb; 92(2):256-63. PubMed ID: 9616522
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
Condemi JJ
Clin Ther; 2001 Sep; 23(9):1529-41. PubMed ID: 11589265
[TBL] [Abstract][Full Text] [Related]
38. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
39. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.
Bacci E; Di Franco A; Bartoli ML; Carnevali S; Cianchetti S; Dente FL; Giannini D; Vagaggini B; Ruocco L; Paggiaro PL
Eur Respir J; 2002 Jul; 20(1):66-72. PubMed ID: 12166584
[TBL] [Abstract][Full Text] [Related]
40. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
